# Role of Immunoscore® in Stage II-III Colorectal Cancer

> **NCT05422547** · — · UNKNOWN · sponsor: **D'Or Institute for Research and Education** · enrollment: 100 (estimated)

## Conditions studied

- Colon Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Immunoscore Colon Test

## Key facts

- **NCT ID:** NCT05422547
- **Lead sponsor:** D'Or Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05422547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05422547, "Role of Immunoscore® in Stage II-III Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05422547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*